Pros and Cons of Inpatient SGLT2i Use for Hyperglycemia and Heart Failure.
Saved in:
| Title: | Pros and Cons of Inpatient SGLT2i Use for Hyperglycemia and Heart Failure. |
|---|---|
| Authors: | Fried H; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Medicine, Lenox Hill Hospital, Northwell Health, New York, NY 10075, USA., Harris YT; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Division of Endocrinology, Diabetes and Metabolism, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY 11040, USA.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Division of Endocrinology, Diabetes and Metabolism, North Shore University Hospital, Northwell Health, Manhasset, NY 11030, USA., Schulman-Rosenbaum R; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Division of Endocrinology, Diabetes and Metabolism, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY 11040, USA. |
| Source: | Journal of the Endocrine Society [J Endocr Soc] 2025 Jan 15; Vol. 9 (2), pp. bvae229. Date of Electronic Publication: 2025 Jan 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Endocrine Society Country of Publication: United States NLM ID: 101697997 Publication Model: eCollection Cited Medium: Internet ISSN: 2472-1972 (Electronic) Linking ISSN: 24721972 NLM ISO Abbreviation: J Endocr Soc Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
